版本:
中国

BRIEF-Neuralstem reports last subject out in phase 2 trial of NSI-189 for major depressive disorder

May 17 Neuralstem Inc

* Neuralstem reports last subject out in phase 2 trial of NSI-189 for major depressive disorder Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐